ABOS vs AMGN: Which Stock is Better?

Side-by-side comparison of Acumen Pharmaceuticals Inc and Amgen Inc in 2026

Comparison Updated:

ABOS

Acumen Pharmaceuticals Inc

$1.86

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricABOSAMGNWinner
Market Cap$114.48M$177.92BAMGN
P/E RatioN/A25.57AMGN
EPS (TTM)$N/A$12.92AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin-36148.3%70.1%AMGN

Analyze ABOS

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ABOS or AMGN a better investment?

Comparing ABOS and AMGN: Acumen Pharmaceuticals Inc has a market cap of $114.48M while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ABOS and AMGN?

ABOS (Acumen Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ABOS or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ABOS or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for ABOS.

Which company is more profitable: ABOS or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to -36148.3% for ABOS.

Which is the larger company: ABOS or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $114.48M for ABOS.

Should I buy ABOS or AMGN in 2026?

Both ABOS and AMGN have investment merit. ABOS trades at $1.86 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ABOS and AMGN stock?

Key differences: Market Cap ($114.48M vs $177.92B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (-36148.3% vs 70.1%).

Popular Stock Comparisons